Skip to main content

Advertisement

Table 1 Patient Characteristics

From: A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy

Characteristic Study Patients (N = 20)
Median age – yrs (range) 65 (38–84)
Sex (no.)  
   Male 10
   Female 10
WHO Performance Score  
   0 14
   1 5
   2 1